Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |